@inproceedings{inproceedings, title  = {{Infrequent zoledronic acid produces sustained increases in bone mineral density (BMD) in patients with cancer treatment induced bone loss (CTIBL)}},

 url = {{}},

 year = {{2006}},

 month = {{1}},

 author = {{Brown JE and Ellis SP and Lester JE and Gutcher S and Khanna T and Purohit O and Coleman RE}},

 volume = {{32}},

 journal = {{CANCER TREATMENT REVIEWS}},

 pages = {{S19-S19}},

 note = {{Accessed on 2024/12/21}}}